Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolonged-release tacrolimus in pediatric liver transplant
NCT06183892Recruiting
- Sponsor
- Renji Hospital
- Start
- Mar 2024
- Primary completion
- Jul 2025
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tacrolimus in Liver transplant rejection, sponsored by Renji Hospital. Primary endpoints: Incidence of biopsy-confirmed acute rejection at 12 months and Incidence of allograft liver fibrosis at 12 months. Started Mar 2024; status: recruiting.
02
Drugs
tacrolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT06183892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06183892.